No Detail Found!

Medical management of infantile hemangioma: is oral propranolol superior to oral prednisolone?

Author(s)
Saad Siddiqui King Abdullah Hospital, Bisha, Kingdom of Saudi Arabia
Muhammad Saaiq MHPE (Medical Education), MBBS (Khyber). Consultant Plastic, Hand and Burns surgeon, Islamabad, Pakistan
Somia Iqbal Wah Medical College,Wah Cantt, Pakistan
Hira Iqbal PAF Hospital,Islamabad, Pakistan
Abstract
Objective: To compare the efficacy of oral propranolol versus oral prednisolone for treating infantile hemangioma. Methodology: This randomized controlled trial was conducted at the Department of Plastic Surgery, Pakistan Institute of Medical Sciences (PIMS), Islamabad from January 2015 to December 2016. Written informed consent was taken from the parents. The trial included 80 patients who were randomly assigned to two treatment groups, each comprising of 40 patients. Patients in Group-A received oral propranolol treatment, whereas patients in the Group-B received oral prednisolone treatment. Greater than 75% regression in size (as determined by the length, width, and height measured in millimeters) of the hemangioma as compared to the pre-treatment status was determined for each group and comparisons were drawn. The percentages of various outcome variables were compared by employing chi-square test. A p-value of less than or equal to 0.05 was regarded as statistically significant. Results: The age of the children ranged from 1-36 months, with a mean of 15.20±10.40 months. The majority (n=51, 63.8%) of them were aged between 1-18 months. There were 33 (41.3%) male whereas 47 (58.7%) female children. Maximal possible matching of the two groups was ensured with regards to the various demographic and clinical entry parameters. The frequency of efficacy was significantly higher (92.5% vs. 25.0%; p=0.000) with propranolol as compared to prednisolone. Similar significant difference was seen across all age and gender groups. Conclusion: Propranolol had superior efficacy, 6-weeks post-treatment irrespective of the patients' age and gender. Hence, oral propranolol should be the preferred choice for treating infantile hemangiomas.
Publication Details
Page(s) 21-25
DOI DOI not available
Published Journal: BMC journal of Medical Sciences, Volume: 4, Issue: 1, Year: 2023

Request the full text from PASTIC

Keywords
infantile hemangioma, Oral propranolol, Efficacy of treatment., Oral Prednisolone
0

Citations

0

Downloads

38

Views